Paul Angaran

Read how they describe their research on their University of Toronto profile.

• Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome

  Circulation · 2026

• Epinephrine Challenge Long-Term Evaluation of Test Performance for the Evaluation of Unexplained Cardiac Arrest and Familial Sudden Death

  JACC: Clinical Electrophysiology · 2026

• Scope and Outcome of Early Repolarization Syndrome in Unexplained Cardiac Arrest: Insights From the National HiRO Registry

  Circulation: Arrhythmia and Electrophysiology · 2026

• Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)

  CIHR · 2026 · Co-investigator

  $1,095,100

• Secondary Prevention of Ventricular Tachycardia in Patient with Cardiomyopathies (END-VT)

  CIHR · 2025 · Co-investigator

  $1,017,448

• Quantifying QRS fragmentation to improve patient selection for cardiac resynchronization therapy

  CIHR · 2021 · Co-investigator

  $344,250